已收录 268921 条政策
 政策提纲
  • 暂无提纲
PGD and aneuploidy screening for 24 chromosomes by genome-wide SNP analysis: seeing the wood and the trees
[摘要] Bisignano et al. (2011) argue that, for preimplantation genetic diagnosis (PGD) of aneuploidy for all 24 chromosomes, microarray-based comparative genomic hybridization (array CGH) is superior to the use of single-nucleotide polymorphism (SNP) genotyping arrays. Published studies indicate that both technologies accurately detect aneuploidy of whole chromosomes or chromosome segments. However, given the extra theoretical resolution and parent-of-origin information provided by SNP-based approaches, these may be particularly suited to certain applications such as PGD of single-gene defects or translocation chromosome imbalance combined with comprehensive detection of aneuploidy. A consensus on how to validate aneuploidy testing and all other clinically relevant information resulting from genome-wide analysis is needed urgently. (C) 2011, Reproductive Healthcare Ltd. Published by Elsevier Ltd. All rights reserved.
[发布日期] 2011-12-01 [发布机构] 
[效力级别]  [学科分类] 
[关键词] aneuploidy;array comparative genomic hybridisation;karyomapping;preimplantation genetic diagnosis;single nucelotide polymorphism;whole genome amplification [时效性] 
   浏览次数:4      统一登录查看全文      激活码登录查看全文